92 related articles for article (PubMed ID: 6682781)
1. Effects of parathyroid hormone or haloperidol-induced catalepsy and nigral GAD activity.
Nicoletti F; Clementi G; Patti F; Prato A; De Giorgio RM; Scapagnini U
Eur J Pharmacol; 1983 Mar; 88(1):135-6. PubMed ID: 6682781
[No Abstract] [Full Text] [Related]
2. Regional differences in cofactor saturation of glutamate decarboxylase (GAD) in discrete brain nuclei of the rat. Effect of repeated administration of haloperidol on GAD activity in the substantia nigra.
Itoh M; Uchimura H
Neurochem Res; 1981 Dec; 6(12):1283-9. PubMed ID: 7339506
[No Abstract] [Full Text] [Related]
3. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity.
Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F
Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172
[No Abstract] [Full Text] [Related]
4. Effects of different doses of apomorphine on GAD activity in rat substantia nigra.
Condorelli DF; Giammona G; Patti F; Nicoletti F; Rampello L; Reggio A; Matera M; Di Giorgio RM
Ital J Neurol Sci; 1981 Aug; 2(3):303-6. PubMed ID: 7341553
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of glutamate decarboxylase in the substantia nigra of the rat.
Ribak CE; Vaughn JE; Saito K; Barber R
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():205-11. PubMed ID: 1005902
[No Abstract] [Full Text] [Related]
6. Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra.
Ribak CE; Vaughn JE; Saito K; Barber R; Roberts E
Brain Res; 1976 Nov; 116(2):287-98. PubMed ID: 788859
[TBL] [Abstract][Full Text] [Related]
7. Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.
Gunne LM; Häggström JE
Psychopharmacology (Berl); 1983; 81(3):191-4. PubMed ID: 6139837
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of estrogens and prolactin on nigral and striatal GAD activity.
Nicoletti F; Patti F; Ferrara N; Canonico PL; Giammona G; Condorelli DF; Scapagnini U
Brain Res; 1982 Jan; 232(1):238-41. PubMed ID: 7055706
[TBL] [Abstract][Full Text] [Related]
9. Effect of haloperidol on glutamate decarboxylase activity in discrete brain areas of the rat.
Itoh M
Psychopharmacology (Berl); 1983; 79(2-3):169-72. PubMed ID: 6405424
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra.
Kim JS; Hassler R
Brain Res; 1975 Apr; 88(1):150-3. PubMed ID: 1122395
[No Abstract] [Full Text] [Related]
11. Subcellular fractions of normal human substantia nigra and caudate nucleus; a study of their morphology and some enzymes including glutamate decarboxylase and choline acetyltransferase.
Hickey SM; Ansell GB; Mitchell K; Pearce GW
J Neurochem; 1976 Oct; 27(4):957-62. PubMed ID: 966028
[No Abstract] [Full Text] [Related]
12. Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres.
Fonnum F; Gottesfeld Z; Grofova I
Brain Res; 1978 Mar; 143(1):125-38. PubMed ID: 630396
[No Abstract] [Full Text] [Related]
13. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
Vamvakidès A
Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
[No Abstract] [Full Text] [Related]
14. Glutamate decarboxylase (GAD) and gamma-aminobutyric acid (GABA) in discrete nuclei of hypothalamus and substantia nigra.
Tappaz ML; Brownstein MJ; Kopin IJ
Brain Res; 1977 Apr; 125(1):109-21. PubMed ID: 856403
[TBL] [Abstract][Full Text] [Related]
15. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
Morelli M; Porceddu ML; Imperato A; Di Chiara G
Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
[TBL] [Abstract][Full Text] [Related]
16. Sulpiride effects on nigral and striatal glutamic acid decarboxylase activity: a possible involvement of prolactin.
Nicoletti F; Canonico PL; Patti F; Rampello L; Condorelli DF; giammona G; Di Giorgio RM; Scapagnini U
Eur J Pharmacol; 1982 Jan; 77(2-3):131-5. PubMed ID: 7060633
[TBL] [Abstract][Full Text] [Related]
17. [Immunocytochemical localization of GAD and CSAD in the rat cerebellum and spinal cord].
Wu H; Song GX; Liu SD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Oct; 8(5):391-3. PubMed ID: 2952314
[No Abstract] [Full Text] [Related]
18. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.
Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE
Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480
[TBL] [Abstract][Full Text] [Related]
19. Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.
Oertel WH; Schmechel DE; Brownstein MJ; Tappaz ML; Ransom DH; Kopin IJ
J Histochem Cytochem; 1981 Aug; 29(8):977-80. PubMed ID: 7024401
[TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity.
Al-Shabibi UM; Davies JA
Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
